i'm thinking the same. and i think things will start

New Post Public Reply Private Reply Replies (2) Message Board
MGK_2 crazyjogger925 #125000
594
i'm thinking the same. and i think things will start coming out of the woodwork pretty darn soon.
1) aggregated safety data submitted, just waiting for acceptance from FDA.
2) with FDA acceptance, hold shall be lifted
3) BLA for HIV can then proceed and who wouldn't want to partner on that?, especially since trial was successful and aggregated safety was good; now BLA just needs writing and we will partner to do that.
4) NASH is probably better than we think and Dr. Noureddin will tell it like it is. Some one wants in on NASH.
5) mTNBC, it has been over 6 months since the BTD application. We were to continued dosing. and we should still be dosing. We have MD Anderson working with PD 1 and PD 2 / PD L1 and PD L2 inhibitors and may find they too are beneficial in mTNBC as they found out in that colon cancer with dolstarimab spelling?? 100% effectivity. I think a company with PD1 inhibitor will want to combine with LL to go for BTD for mTNBC using our new data for PFS and OS which would blow away current PFS and OS.

any one of these things happen, we approach $9 again

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Navigating AI's New Era: Dresner's 2026 Findings

Updated Category News Views 7

Big Insights in the AI World of 2026 Well folks, if there's one thing making waves in the boardrooms this year, it's AI. Dresner Advisory Services just threw down a gauntlet for companies with their fresh batch of reports focused on the dizzying world of AI. They ripped right into it, exploring how firms can bag a heap of benefits and deal with the hurdles that come with...

Continue Reading
Castillo Engineering Gears Up with New VP Appointments

Updated Category News Views 3

New Leadership to Drive Expansion In a boost to its commitment to scaling up, Castillo Engineering, based in Maitland, Florida, has roped in two veterans from the renewables sector as vice presidents. Aaron Carrillo and Devin Radovich, who share a history of successful collaboration at Renewable Energy Systems Americas (RES), are set to guide Castillo's growth in the...

Continue Reading
Annex Brands Grows with Bastrop's PostalAnnex Opening

Updated Category News Views 4

New PostalAnnex Location Opens in Bastrop, TX Here's a fresh chapter in the books for Annex Brands, Inc. They've just cut the ribbon on a brand spanking new PostalAnnex in Bastrop, Texas, handing the reins over to eager fresh faces, Chetan Modi and Karan Desai. And you know what? This ain't just any regular location. It's a one-stop-shop for anything you could need, from...

Continue Reading
Molex's VersaBeam Mini Pushes AI Data Center Limits

Updated Category News Views 3

Game-Changer for AI Data Centers? Across the tech landscape, space is a premium, and Molex's new VersaBeam Mini arrives like a hail Mary in the fourth quarter. In AI data centers, squeezing down every single component counts—especially when optical density's in play. What we're seeing here is a potential paradigm shift. A 3x density improvement from a tiny 3.5 x 9 mm...

Continue Reading
Tenera Care's Tech Triumph: Halving Falls with Simplicity

Updated Category News Views 6

Every once in a while, a piece of tech comes along that makes you sit up and say, ‘Now that’s a game-changer!’ And with the recent rave reviews, Tenera Care seems to hit just that sweet spot for folks in the senior living game. By handing Dublin Glenn Memory Care the gold in the KISS category at the 2026 McKnight's Technology Awards, it’s clear the industry is...

Continue Reading
HNTB Expands in Capital Region: A Strategic Move

Updated Category News Views 2

Breaking New Ground in Arlington and Baltimore Deepening their stake in the Capital Region's future, HNTB has thrown open new office doors in Arlington, Virginia, and Baltimore, Maryland. We're not just talking fancy buildings, folks—this is about securing a piece of the infrastructure pie that's only going to get bigger and tastier. Infrastructure's the backbone of...

Continue Reading
U.N. Leaders Converge at NYSE, Forus Soars to $3B Valuation

Updated Category News Views 5

A Busy Morning at the NYSE with Key Guests and Global Events In a world where high-stakes diplomacy and roaring market bells go hand in hand, today brings the U.S. Secretary of State, Marco Rubio, to the New York Stock Exchange. With the 81st Session of the United Nations General Assembly shaking up the Big Apple, the city finds itself at the intersection of politics and...

Continue Reading
NACD Honors Top Board Leaders with 2026 Awards

Updated Category News Views 12

Celebrating Boardroom Mavericks at NACD Gala September 2026 has brought some sparkling recognition to the elites guiding today's corporate governance landscapes. The National Association of Corporate Directors (NACD) has announced their Directorship 100 honorees, tipping their hats to stellar individuals firing on all cylinders in the boardroom. Who's Getting the Nod?...

Continue Reading
Lititz Mutual Embraces AI with Guidewire ProNavigator

Updated Category News Views 6

It's not every day you see a company like Lititz Mutual making moves in the artificial intelligence (AI) arena. Based out of Lititz, Pennsylvania, this insurance firm has decided to shake things up with Guidewire's ProNavigator AI assistant. Forging New Paths in Insurance Lititz Mutual is set to inject some serious tech into their operations. The goal? Make life easier...

Continue Reading
Anixa Expands Global Footprint with Aussie Patent

Updated Category News Views 5

Breaking New Ground in Cancer Immunotherapy Today feels like a pivotal day for Anixa Biosciences. Their announcement about securing a patent in Australia for their trailblazing breast cancer vaccine is like planting a flag on new, promising territory. This is no minor step; it's a strategic leap for the company as it strengthens its intellectual grip on the global...

Continue Reading

Top 5 Most Recently Viewed Articles

Commercial Metals Company Q3 Fiscal 2025 Performance Overview

Updated Category News Views 275

Commercial Metals Company Reports Impressive Q3 Results Commercial Metals Company (NYSE: CMC) has announced remarkable financial results for the third quarter of fiscal 2025, demonstrating strength across its various segments. The company reported net earnings of $83.1 million, equating to $0.73 per diluted share, while adjusted earnings amounted to $84.4 million or $0.74...

Continue Reading
Understanding the Impact of Tariffs on the Automotive Industry

Updated Category News Views 361

Tariffs on Foreign Vehicles: A Looming Reality The discussion surrounding tariffs on foreign automobiles is escalating, especially after recent remarks by financial commentator Jim Cramer. According to Cramer, the expectation of tariffs on cars is not new, given that over half of the vehicles sold in the U.S. come from abroad. The Background of Tariff Discussions In a...

Continue Reading
The Future of Intel in the Dow: What to Expect Next

Updated Category News Views 88

Understanding the Dow Jones Industrial Average For more than 128 years, the Dow Jones Industrial Average (DJI) has served as a vital indicator of the stock market's overall health, reflecting the performance of 30 major multinational companies. When it first launched, the index included just 12 primarily industrial firms. Today, it features a diverse array of businesses...

Continue Reading
Abbott Labs Exceeds Earnings Expectations in Latest Report

Updated Category News Views 48

Abbott Labs Reports Strong Earnings Performance Abbott Labs (NYSE: ABT) has recently announced its impressive third-quarter earnings, showcasing a robust performance that exceeded analyst expectations. The company reported an earnings per share (EPS) of $1.21, which is $0.01 above the estimated EPS of $1.20. This positive surprise indicates not only Abbott's strength in...

Continue Reading
Market Anticipations for RET Fusion Targeted Therapies Rising

Updated Category News Views 99

The Rising Landscape of RET Fusion Targeted Therapies The field of RET fusion-targeted therapies is experiencing promising growth, primarily driven by increased awareness regarding the RET gene fusions that play a significant role in various cancers. Recent clinical trials have shown encouraging outcomes with targeted agents like selpercatinib and pralsetinib that have...

Continue Reading